Waddell & Reed Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-400,000
| Closed | -$8.99M | – | 536 |
|
|
2018
Q1 | $8.99M | Sell |
400,000
-2,481,692
| -86% | -$55.8M | 0.02% | 434 |
|
|
2017
Q4 | $86.8M | Sell |
2,881,692
-184,572
| -6% | -$5.56M | 0.19% | 132 |
|
|
2017
Q3 | $116M | Sell |
3,066,264
-77,147
| -2% | -$2.91M | 0.26% | 106 |
|
|
2017
Q2 | $87.7M | Buy |
3,143,411
+51,434
| +2% | +$1.43M | 0.19% | 142 |
|
|
2017
Q1 | $106M | Buy |
3,091,977
+1,912
| +0.1% | +$65.7K | 0.23% | 120 |
|
|
2016
Q4 | $89.1M | Buy |
3,090,065
+1,143,649
| +59% | +$33M | 0.2% | 141 |
|
|
2016
Q3 | $61.9M | Buy |
1,946,416
+103,599
| +6% | +$3.3M | 0.13% | 180 |
|
|
2016
Q2 | $59.8M | Sell |
1,842,817
-206,730
| -10% | -$6.71M | 0.13% | 183 |
|
|
2016
Q1 | $57.3M | Buy |
2,049,547
+278,294
| +16% | +$7.78M | 0.11% | 187 |
|
|
2015
Q4 | $63.1M | Sell |
1,771,253
-333,651
| -16% | -$11.9M | 0.1% | 187 |
|
|
2015
Q3 | $69.6M | Sell |
2,104,904
-147,652
| -7% | -$4.88M | 0.11% | 185 |
|
|
2015
Q2 | $94.3M | Sell |
2,252,556
-383,915
| -15% | -$16.1M | 0.13% | 175 |
|
|
2015
Q1 | $85.9M | Buy |
2,636,471
+285,722
| +12% | +$9.31M | 0.12% | 188 |
|
|
2014
Q4 | $74.6M | Buy |
2,350,749
+324,625
| +16% | +$10.3M | 0.1% | 190 |
|
|
2014
Q3 | $50.2M | Buy |
2,026,124
+492,628
| +32% | +$12.2M | 0.07% | 225 |
|
|
2014
Q2 | $34.6M | Buy |
1,533,496
+655,786
| +75% | +$14.8M | 0.05% | 282 |
|
|
2014
Q1 | $21.4M | Buy |
+877,710
| New | +$21.4M | 0.03% | 333 |
|